L'Oréal Garnier discontinued stemoxydine serum so how can people still buy it? Product 1/9/2025
L'Oréal Garnier discontinued their stemoxydine serum, raising concerns about the authenticity of products still sold online. Alternatives suggested include other brands' stemoxydine products, though some believe stemoxydine is ineffective.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity topical fin with garnier fructis stemoxydine
Using topical finasteride mixed with Garnier Fructis Stemoxydine for hair loss. Users discuss effectiveness, dosage, and potential risks.
community Combining Stemoxydine + Topical Minoxidil
Combining stemoxydine with topical minoxidil for hair loss treatment. Users discuss application order and effectiveness, with some skepticism about stemoxydine's benefits.
community What's an anecdotal treatment you nevertheless swear by?
Stemoxydine is highly recommended for hair loss, preferred over Minoxidil due to fewer side effects and dependency. The user also uses finasteride, Pur'ador shampoo, and suggests cold showers and spicy food as part of their routine.
community How much do you pay a Month for your Medication?
The user spends around 200€ monthly on hair loss treatments, including Kx826, Alfatradiol, Minoxidil, Nizoral Shampoo, Stemoxydine, Tretinoin, and a Dermastamp. The total cost is approximately 220$.
community Perifollicular Fibrosis and its role in androgenetic alopecia. Is Aminexil/Kopexil a must for anyone with AGA?
Aminexil/Kopexil may help reduce hair loss by addressing perifollicular fibrosis in androgenetic alopecia, but it lacks the extensive clinical backing of finasteride and minoxidil. Some users find it effective, but availability and cost are issues, especially in the US where it's not FDA-approved.
Related Research
6 / 6 resultsresearch Regulation of stem cell fate by HSPGs: implication in hair follicle cycling
This review discusses the role of heparan sulfate proteoglycans in regulating stem cell fate and highlights their potential as targets for addressing hair loss, without reporting new clinical results.
research Trichoscopic Evaluation of the Effectiveness of Topical Stemoxydine for Hair Restoration in Androgenetic Alopecia: A Prospective Pre–Post Single‐Arm Exploratory Study
Topical Stemoxydine improves hair density in androgenetic alopecia with few side effects.
research Telogen Effluvium, Diagnosis and Management: A Narrative Review
This review discusses telogen effluvium, including its causes, symptoms, diagnostic methods, and treatment strategies, without presenting new clinical findings.
research Telogen Effluvium
This review discusses telogen effluvium, a common form of hair loss, and reports no new clinical results; the authors outline possible causes, typical prognosis, and management strategies.
research Telogen Effluvium
This review discusses telogen effluvium, including its triggers, clinical presentations, and management options, and does not report new research findings, emphasizing the need for identification and exclusion of underlying causes.
research 289 Immortalization of primary human dermal papilla cells by Bmi-1 and TERT
This study reported that introducing the TERT and Bmi1 genes into mouse dermal papilla cells resulted in immortal cells capable of inducing new hair follicles in vivo, and human immortal DPCs were also developed.